China National Accord Medicines Corp Ltd Capital Reinvestment Ratio
China National Accord Medicines Corp Ltd capital reinvestment ratio. China National Accord Medicines Corp Ltd (200028) has a Capital Reinvestment Ratio of 0.03x as of June 2025, meaning it reinvests 0% of its operating cash flow (HK$1.83 Billion) in capital expenditures (HK$50.09 Million). Check 200028 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of China National Accord Medicines Corp Ltd (1998–2025)
Capital reinvestment ratio of China National Accord Medicines Corp Ltd from 1998 to 2025. This chart tracks China National Accord Medicines Corp Ltd's Capital Reinvestment Ratio across 27 annual periods. Also explore 200028 shareholders equity momentum to track the company's year-over-year net asset growth rate.
China National Accord Medicines Corp Ltd Capital Reinvestment Ratio by Year (1998–2025)
China National Accord Medicines Corp Ltd capital reinvestment ratio by year from 1998 to 2025. For the full cash flow conversion analysis, see 200028 cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (HKD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.13x | HK$1.64 Billion | HK$217.35 Million | ▲ +53.5% |
| 2024 | 0.09x | HK$3.27 Billion | HK$282.70 Million | ▼ -21.2% |
| 2023 | 0.11x | HK$2.94 Billion | HK$322.21 Million | ▼ -12.8% |
| 2022 | 0.13x | HK$2.56 Billion | HK$322.19 Million | ▼ -43.8% |
| 2021 | 0.22x | HK$1.66 Billion | HK$370.43 Million | ▲ +14.5% |
| 2020 | 0.20x | HK$1.50 Billion | HK$293.83 Million | ▲ +59.5% |
| 2019 | 0.12x | HK$2.00 Billion | HK$245.17 Million | ▼ -36.6% |
| 2018 | 0.19x | HK$1.32 Billion | HK$255.48 Million | ▲ +21.5% |
| 2017 | 0.16x | HK$1.29 Billion | HK$204.35 Million | ▼ -11.9% |
| 2016 | 0.18x | HK$1.47 Billion | HK$265.89 Million | ▼ -0.6% |
| 2015 | 0.18x | HK$1.05 Billion | HK$190.36 Million | ▼ -43.9% |
| 2013 | 0.32x | HK$465.03 Million | HK$150.50 Million | ▼ -45.8% |
| 2012 | 0.60x | HK$323.96 Million | HK$193.57 Million | ▼ -31.7% |
| 2011 | 0.88x | HK$227.32 Million | HK$198.97 Million | ▲ +110.6% |
| 2010 | 0.42x | HK$428.16 Million | HK$177.99 Million | ▲ +9.4% |
| 2009 | 0.38x | HK$270.85 Million | HK$102.94 Million | ▲ +10.3% |
| 2008 | 0.34x | HK$246.58 Million | HK$84.98 Million | ▼ -57.7% |
| 2007 | 0.81x | HK$87.70 Million | HK$71.41 Million | ▲ +25.2% |
| 2006 | 0.65x | HK$181.73 Million | HK$118.22 Million | ▲ +90.5% |
| 2005 | 0.34x | HK$148.28 Million | HK$50.62 Million | ▲ +213.6% |
| 2004 | 0.11x | HK$130.30 Million | HK$14.18 Million | ▼ -82.1% |
| 2003 | 0.61x | HK$81.22 Million | HK$49.36 Million | ▼ -35.0% |
| 2002 | 0.94x | HK$28.76 Million | HK$26.90 Million | ▲ +85.3% |
| 2001 | 0.50x | HK$71.16 Million | HK$35.91 Million | ▼ -79.5% |
| 2000 | 2.47x | HK$8.52 Million | HK$21.01 Million | ▲ +104.6% |
| 1999 | 1.21x | HK$22.84 Million | HK$27.54 Million | ▼ -39.5% |
| 1998 | 1.99x | HK$5.21 Million | HK$10.38 Million | — |